Tesofensine 500mcg Capsules

Tesofensine is a small molecule, not a peptide. It has no amino acid sequence, no peptide bonds and no receptor of the classes described elsewhere in this catalogue, and handling guidance written for lyophilised peptides does not apply to it.

It is characterised in published work as a triple monoamine reuptake inhibitor, acting at the transporters for serotonin, noradrenaline and dopamine rather than at a G-protein-coupled receptor.

Supplied as 500 microgram capsules in a 60-count bottle. The microgram scale reflects the potency typical of small-molecule monoamine transporter ligands, several orders of magnitude below the milligram presentations used for peptides.

Supplied ready to use rather than as a lyophilised cake, so no reconstitution step applies. Storage follows the container: sealed, away from direct light, at controlled ambient temperature unless the label states otherwise.

Because there is no freeze-drying step, the stability window is set at manufacture rather than by how the vial is handled afterwards, and the expiry on the container is the operative date.

Every batch is independently tested through seven rounds of analysis. Identity is confirmed by mass spectrometry and purity quantified by reverse-phase HPLC, with the resulting Certificate of Analysis published against the specific batch rather than the product line.

Testing is performed by third-party laboratories operating to ISO 17025. The COA for the batch currently shipping is linked from this page and archived at /lab-tests.